Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.2036.8263.14-3.4820.95

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 2.20 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20252.20
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.2
-94.02
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,543.7 Cr 1.3% -7.1% -51.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

1.3%

-7.1%

-51.7%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses